Green Tea Reduces LDL Oxidability and Improves Vascular Function

REFERENCES

• Hertog MG, Feskens EJ, Kromhout D: Antioxidant flavonols and coronary heart disease risk. Lancet349 :699 ,1997 .
   PubMed Web of Science ®Google Scholar
• Sesso HD, Gaziano JM, Buring JE, Hennekens CH: Coffee and tea intake and the risk of myocardial infarction. Am J Epidemiol1149 :162– 167,1999 .
   Google Scholar
• Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC: Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med125 :384– 389,1996 .
   PubMed Web of Science ®Google Scholar
• Rice-Evans CA, Miller NJ, Paganga G: Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Rad Biol Med20 :933– 956,1996 .
   PubMed Web of Science ®Google Scholar
• Hamilton CA: Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis. Pharmacol Ther74 :55– 72,1997 .
   PubMed Web of Science ®Google Scholar
• Witztum JL, Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest88 :1785– 1792,1991 .
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest84 :1086– 1095,1989 .
   PubMed Web of Science ®Google Scholar
• Radulescu L, Stancu C, Antohe F: Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins. Med Sci Monit10 :BR207– 214,2004 .
   PubMed Web of Science ®Google Scholar
• Karvonen J, Paivansalo M, Kesaniemi YA, Horkko S: Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis. Circulation108 :2107– 2112,2003 .
   PubMed Web of Science ®Google Scholar
• Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum J: Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet339 :883– 887,1992 .
   PubMed Web of Science ®Google Scholar
• Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, Yonemura A, Hara Y, Nakamura H: Effect of tea flavonoids supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr66 :261– 266,1997 .
   PubMed Web of Science ®Google Scholar
• Serafini M, Ghiselli A, Ferro-Luzzi A: In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr50 :28– 32,1996 .
   PubMed Web of Science ®Google Scholar
• Van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB: Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr66 :1125– 1132,1997 .
   PubMed Web of Science ®Google Scholar
• McAnlis GT, McEneny J, Pearce J, Young IS: Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr52 :202– 206,1998 .
   PubMed Web of Science ®Google Scholar
• Locher R, Emmanuele L, Suter PM, Vetter W, Barton M: Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. Eur J Pharmacol434 :1– 7,2002 .
   PubMed Web of Science ®Google Scholar
• Tinahones FJ, Gomez-Zumaquero JM, Rojo-Martinez G, Cardona F, Esteva de Antonio IE, Ruiz de Adana MS, Soriguer FJ: Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population. Metabolism51 :429– 431,2002 .
   PubMed Web of Science ®Google Scholar
• Tinahones FJ, Gomez-Zumaquero JM, Garrido-Sanchez L, Garcia-Fuentes E, Rojo-Martinez G, Esteva I, Ruiz de Adana MS, Cardona F, Soriguer F: Influence of age and sex on levels of anti-oxidized LDL antibodies and immune complexes in the general population. J Lipid Res46 :452– 457,2005 .
   PubMed Web of Science ®Google Scholar
• Wu R, de Faire U, Lemme C et al. Autoantibodies to OxLDL are decreased in individuals with borderline hypertension. Hipertensión33 :53– 59,1999 .
   PubMed Web of Science ®Google Scholar
• Hodgson JM, Puddey IB, Burke V, Watts GF, Beilin LJ: Regular ingestion of black tea improves brachial artery vasodilator function. Clin Sci (Lond)102 :195– 201,2002 .
   PubMed Web of Science ®Google Scholar
• Widlansky ME, Biegelsen ES, Hamburg NM, Duffy SJ, Keaney JF Jr, Vita JA: Coronary endothelial dysfunction is not rapidly reversible with ascorbic acid. Free Radic Biol Med36 :123– 130,2004 .
   PubMed Web of Science ®Google Scholar
• Greene EL, Velarde V, Jaffa AA: Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension35 :942– 947,2000 .
   PubMed Web of Science ®Google Scholar
• Ruef J, Rao GN, Li F, Bode C, Patterson C, Bhatnagar A, Runge MS: Induction of rat aortic smooth muscle cell growth by the lipid peroxidation product 4-hydroxy-2-nonenal. Circulation97 :1071– 1078,1998 .
   PubMed Web of Science ®Google Scholar
• Ahn H.Y, Hadizadeh K.R, Seul C, Yun Y.P, Vetter H, Sachinidis A: Epigallocathechin-3-gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Mol Biol Cell10 :1093– 1104,1999 .
   PubMed Web of Science ®Google Scholar
• Princen HM, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA, Meinders AE, Pijl H: No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol18 :833– 841,1998 .
   PubMed Web of Science ®Google Scholar
• van het Hof KH, Wiseman SA, Yang CS, Tijburg LBM: Plasma and lipoprotein levels of tea catechins following repeated tea consumption. Proc Soc Exp Biol Med220 :203– 209,1999 .
   PubMed Web of Science ®Google Scholar
• Carbonneau MA, Leger CL, Monnier L, Bonnet C, Michel F, Fouret G, Dedieu F, Descomps B: Supplementation with wine phenolic compounds increases the antioxidant capacity of plasma and vitamin E of low-density lipoprotein without changing the lipoprotein Cu(2+)-oxidizability: possible explanation by phenolic location. Eur J Clin Nutr51 :682– 690,1997 .
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol186 :407– 421,1990 .
   PubMed Web of Science ®Google Scholar
• Lee C: Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical obsorbing capacity and inhibition of LDL peroxidation. Clin Chim Acta295 :141– 154,2000 .
   PubMed Web of Science ®Google Scholar
• Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL: Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA86 :1372– 1376,1989 .
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Wu R, Dearing LD, Matsuura E: Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? Circulation110 :2552– 2558,2004 .
   PubMed Web of Science ®Google Scholar
• Inoue T, Uchida T, Kamishirado H, Takayanagi K, Hayashi T, Morooka S: Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. J Am Coll Cardiol37 :775– 779,2001 .
   PubMed Web of Science ®Google Scholar
• Rossi GP, Cesari M, De Toni R, Zanchetta M, Maiolino G, Pedon L, Ganzaroli C, Maiolino P, Pessina AC: Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients. Circulation108 :2467– 2472,2003 .
   PubMed Web of Science ®Google Scholar
• Craig WY, Poulin SE, Neveux LM, Palomaki GE, Dostal-Johnson DA, Ledue TB, Ritchie RF: Anti-oxidized LDL antibodies and antiphospholipid antibodies in healthy subjects: relationship with lipoprotein- and oxidation-related analytes. J Autoimmun8 :713– 726,1995 .
   PubMed Web of Science ®Google Scholar
• Imai K, Nakachi K: Cross sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ310 :693– 696,1995 .
   PubMed Web of Science ®Google Scholar
• Vinson JA, Dabbagh YA: Effect of green and black tea supplementation on lipids, lipid oxidation and fibrinogen in the hamster: mechanisms for the epidemiological benefits of tea drinking. FEBS Lett433 :44– 46,1998 .
   PubMed Web of Science ®Google Scholar